ADMA Biologics, Inc. (ADMA)
15.59
-0.69
(-4.24%)
USD |
NASDAQ |
Feb 12, 16:00
15.56
-0.02
(-0.16%)
After-Hours: 20:00
ADMA Biologics Free Cash Flow : 40.61M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Arcutis Biotherapeutics, Inc. | -48.24M |
| Marker Therapeutics, Inc. | -14.82M |
| CorMedix, Inc. | 74.42M |
| Savara, Inc. | -99.27M |
| Viridian Therapeutics, Inc. | -326.34M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 13.29M |
| Cash from Investing (Quarterly) | -14.37M |
| Cash from Financing (Quarterly) | -27.82M |
| Free Cash Flow Per Share (Quarterly) | -0.0044 |
| Free Cash Flow to Equity (Quarterly) | -0.373M |
| Free Cash Flow to Firm (Quarterly) | 0.2092M |
| Free Cash Flow Yield | 1.06% |